Villöz Adenom ve Mesane Adenokarsinomu

Cheng L, Montironi R, Bostwick DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol. 1999;23(7):764–771.

Seibel JL, Prasad S, WeissRE, et al. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy. Hum Pathol. 2002;33(2):236–241.

KatoY, Konari S, Obara W, et al. Concurrence of villous adenoma and non-muscle invasive bladder cancer arising in the bladder: a case report and review of the literature. BMC Urol. 2013;13:36.

Nakamura Y, Orikasa K, Fujishima F, et al. A case of villous adenoma of the urinary bladder with tubulovillous architecture: characterization by immunohistochemical analysis. Pol J Pathol. 2011;62:179-182.

Channer JL, Williams JL, Henry L. Villous adenoma of the bladder. J Clin Pathol. 1993;46:450-452.

Mitra S, Chatterjee D, Das A, et al. Urothelial tumors with villous morphology: histomorphology and role of immunohistochemistry in diagnosis. APMIS. 2018;126:191-200.

Adegboyega PA, Adesokan A. Tubulovillous adenoma of the urinary bladder. Mod Pathol. 1999;12(7):735–738.

Corica FA, Husmann DA, Churchill BM, et al. Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology. 1997;50(3):427–431.

Wang J, Manucha V. Villous adenoma of the urinary bladder: a brief Review of the literature. Arch Pathol Lab Med. 2016;140 (1):91–93.

Turcan D, Acikalin MF, Yilmaz E, et al. Nephrogenic adenoma of the urinary tract: a 6-year single center experience. Pathol Res Pract. 2017;213:831-838.

Kryvenko ON, Epstein JI. Mimickers of urothelial neoplasia. Ann Diagn Pathol. 2019;38:11-19.

Eble JN, Hull MT, Rowland RG, et al: Villous adenoma of the urachus with mucusuria: A light and electron microscopic study. J Urol. 1986;135:1240-1244.

Thomas AA, Stephenson AJ, Campbell SC, et al. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40:108–116. Doi: 10.1016/j.humpath.2008.06.022.

Wang HL, Lu DW, Yerian LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol. 2001;25:1380–1387.

Mostofi FK, Thomson RV, Dean AL Jr. Mucous adenocarcinoma of the urinary bladder. Cancer. 1955;8:741–758.

Sheldon CA, Clayman RV, Gonzalez R, et al. Malignant urachal lesions. J Urol. 1984;131:1–8.

Roy S, Smith MA, Cieply KM, et al. Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge. Diagn Pathol. 2012; 7: 151.

Melicow MM. Tumors of the urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. J Urol. 1955;74:498–521.

Epstein, J.I., Amin, M.B. & Reuter, V.E. (2010). Glandular Lesions. In: J. I. Epstein, M. B. Amin & V. E. Reuter (Eds). Biopsy Interpretation of the Bladder (2nd ed., pp.180-213). Philadelphia.

Ghoneim MA, Abdel-Latif M, El-Mekresh M, et al. Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Years Later. J Urol 2008;180: 121-127.

el-Mekresh MM, el-Baz MA, Abol-Enein H, et al. Primary adenocarcinoma of the urinary bladder: a report of 185 cases. Br J Urol. 1998;82:206-212.

Shaaban AA, Elbaz MA and Tribukait B. Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases. Urology. 1998;51:469-476.

Eble, J., Sauter, G., Epstein, J.I., et al. (2004). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press.

Nakaguro M, Tsuzuki T, Shimada S, et al. Adenocarcinoma arising in urinary bladder endocervicosis. Pathol Int. 2016;66(2):108-13.

Shigehara K, Taya T and Hisazumi H. Primary adenocarcinoma in the bladder diverticulum. Scand J Urol Nephrol. 2008;42: 481-3.

Fu LY, Adeniran AJ. Adenocarcinoma Arising from a Bladder Diverticulum. J Urol. 2015;194(2):527-8.

Balachandra B, Swanson PE, Upton MP, et al. Adenocarcinoma arising in a gastrocystoplasty. J Clin Pathol 2007;60:85-7.

Zhang X, Gupta R, Nicastri AD. Bladder adenocarcinoma following gastrocystoplasty. J Pediatr Urol. 2010;6(5):525-7.

Islam MM, Saltzman AF, Carrasco A Jr, et al. Incidental Discovery of Adenocarcinoma of an Augmented Bladder in a Patient With Myelomenigocele Undergoing Cystolithotomy. Urology. 2018;113:203-205.

Grignon DJ, Ro JY, Ayala AG, et al. Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer. 1991;67:2165-2172.

Smith AK, Hansel DE, Jones JS. Role of Cystitis Cystica et Glandularis and Intestinal Metaplasia in Development of Bladder Carcinoma. Urology. 2008;71:915-918.

Del Sordo R, Bellezza G, Colella R, et al. Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases. Appl Immunohistochem Mol Morphol. 2009;17:18–22.

Bernstein SA, Reuter VE, Carroll PR,et al. Primary signet-ring cell carcinoma of urinary bladder. Urology. 1988;31:432-436.

Poore TE, Egbert B, Jahnke R,et al. Signet ring cell adenocarcinoma of the bladder: linitis plastica variant. Arch Pathol Lab Med. 1981;105:203-204.

Sekino Y, Mochizuki H, Kuniyasu H. A 49-year-old woman presenting with hepatoid adenocarcinoma of the urinary bladder: a case report. J Med Case Rep. 2013;7:12.

Lopez-Beltran A, Luque RJ, Quintero A. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003;442:381-387.

Dadhania V, Czerniak B, Guo CC. Adenocarcinoma of the urinary bladder. Am J Clin Exp Urol. 2015;3:51-63.

Raspollini MR, Nesi G, Baroni G. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. Appl Immunohistochem Mol Morphol. 2005;13:358–362. doi:10.1097/01.pai.0000136552.44045.0f

Silver SA, Epstein JI. Adenocarcinoma of the colon simulating primary urinary bladder neoplasia. A report of nine cases. Am J Surg Pathol. 1993;17:171–178.

Suh N, Yang XJ, Tretiakova MS, et al. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol. 2005;18:1217–1222.

Gopalan A, Sharp DS, Fine SW, et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol. 2009;33:659–668. doi: 10.1097/PAS.0b013e31819aa4ae

Broede A, Oll M, Maurer A, et al. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder. J Clin Pathol. 2016;69(4):307-12.

Epstein JI, Egevad L, Humphrey PA, Montironi R; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol. 2014;38: e6-e19.

Svanholm H. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase. Acta Pathol Microbiol Immunol Scand A. 1986;94:7-12.

Ford TF, Butcher DN, Masters JR, et al. Immunocytochemical Localisation of Prostate-specific Antigen: Specificity and Application to Clinical Practice. Br J Urol. 1985;57:50-55.

Torenbeek R, Lagendijk JH, Van Diest PJ. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma. Histopathology. 1998; 32:20-27.

Woodard AH, Yu J, Dabbs DJ, et al. NY-BR-1 and PAX8 Immunoreactivity in Breast, Gynecologic Tract, and Other CK7+ Carcinomas: Potential Use for Determining Site of Origin. Am J Clin Pathol. 2011;136:428-435.

Kong CS, Beck AH, Longacre TA. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas. Am J Surg Pathol. 2010;34:915-926.

Yang CC, Chu KC, Chen HY. Expression of p16 and Cyclin D1 in Bladder Cancer and Correlation in Cancer Progression. Urol Int. 2002;69:190-194.

Jacobs LB, Brooks JD, Epstein JI. Differentiation of colonic metaplasia from adenocarcinoma of urinary bladder. Hum Pathol. 1997;28:1152-1157.

Zaghloul MS, Nouh A, Nazmy M. Longterm results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol. 2006;24:13-20.

Rogers CG, Palapattu GS, Shariat SF, et al. Clinical Outcomes Following Radical Cystectomy for Primary Nontransitional Cell Carcinoma of the Bladder Compared to Transitional Cell Carcinoma of the Bladder. J Urol. 2006;175:2048-2053.

Tuna B. Adenocarcinoma of the urinary bladder. Journal of Urological Surgery. 2018;5(4):233-238.

Schultz RE, Bloch MJ, Tomaszewski JE, et al. Mesonephric adenocarcinoma of the bladder. J. Urol. 1984;132:263–5.

Sugao H, Suzuki S, Yokokawa M, et al. Clear cell adenocarcinoma of the bladder: Report of a case. Jpn. J. Urol. 1983;74:1447–52.

Kuwahara M, Nishitani M, Matsushita K, et al. Clear cell adenocarcinoma of the bladder: A case report. Jpn. J. Clin. Urol. 1993;47:418–21.

Drew PA, Murphy WM, Civantos F, et al. The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature. Hum Pathol. 1996;27:248-252.

Oliva E, Young RH. Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases. Mod Pathol. 1996;9:513-520.

Gilcrease MZ, Delgado R, Vuitch F, et al. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: A histopathologic and immunohistochemical comparison. Hum Pathol. 1998;29:1451-1456.

Oliva E, Amin MB, Jimenez R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol. 2002;26:190-7.

Kösem M, Şengül E. Clear cell adenocarcinoma of urinary bladder. Scand J Urol Nephrol. 2005;39(1):89-92.

Brimo F, Herawi M, Sharma R, et al. Hepatocyte nuclear factor-1βexpression in clear cell adenocarcinomas of the bladder and urethra:Diagnostic utility and implications for histogenesis. Hum Pathol. 2011;42(11):1613–9.

Sethi S, Dhawan S, Chopra P. Clear cell adenocarcinoma of urinary bladder: A case report and review. Urol Ann. 2011;3(3):151–154.

Alsanjari N, Lynch MJ, Fisher C, et al. Vesical clear cell adenocarcinoma. V. nephrogenic adenoma: a diagnostic problem. Histopathology. 1995;27:43-49.

Adeniran AJ, Tamboli P. Clear cell adenocarcinoma of the urinary bladder: A short review. Arch Pathol Lab Med. 2009;133:987–91.

Young RH, Scully RE. Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. Am J Surg Pathol. 1985;9:816-26.

Young RH, Scully RE. Nephrogenic adenoma. A report of 15 cases, review of the literature, and comparison with clear cell adenocarcinoma of the urinary tract. Am J Surg Pathol. 1986;10:268-75.

Herawi M, Drew PA, Pan CC, et al. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma. Hum Pathol. 2010;41(4):594-601.

Shiraishi K, Mohri J, Inoue R et al. Metastatic renal cell carcinoma to the bladder 12 years after radical nephrectomy Int J Urol. 2003;10:453–455.

Sim SJ, Ro JY, Ordonez NG, et al. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Mod Pathol. 1999;12: 351-355.

Pan CC, Yu IT, Yang AH, et al. Clear cell myomelanocytic tumor of the urinary bladder. Am J Surg Pathol. 2003;27:689–92.

Pan CC, Chiang H, Chang YH, et al. Tubulocystic clear cell adenocarcinoma arising within the prostate. Am J Surg Pathol. 2000;24:1433–1436.

Singh H, Flores-Sandoval N, Abrams J. Renal-type clear cell carcinoma occurring in the prostate. Am J Surg Pathol. 2003;27:407–410.

Zhou Z, Kinslow CJ, Wang P, et al. Clear Cell Adenocarcinoma of the Urinary Bladder Is a Glycogen-Rich Tumor with Poorer Prognosis. J Clin Med. 2020;3;9(1):138.